Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative

Dan D Matlock1, Carolyn T Nowels, Frederick A Masoudi

  • 1Department of Medicine, School of Medicine, University of Colorado, Aurora, Colorado 80045, USA. daniel.matlock@ucdenver.edu

Insights

Cardiologists often focus on implantable cardioverter-defibrillator (ICD) benefits, potentially overshadowing risks for patients. This impacts shared decision-making for ICD implantation, necessitating improved discussion processes.

Area of Science:

  • Cardiology
  • Medical Decision Making
  • Patient-Centered Care

Background:

  • Implantable cardioverter-defibrillators (ICDs) reduce mortality but carry risks.
  • Informed periprocedural decision-making requires understanding both benefits and risks of ICDs.

Purpose of the Study:

  • To explore cardiologists' and patients' perspectives on decision-making for ICD implantation.
  • To understand how patient-centered care principles apply to ICD implantation decisions.

Main Methods:

  • Qualitative study using semi-structured, in-depth interviews.
  • Interviewed 11 cardiologists and 20 patients (ICD recipients and decliners).
  • Analyzed data using the constant comparative method through a patient-centered care lens.

Main Results:

  • Cardiologists varied in emphasizing ICD risks, often influenced by guidelines.
  • Many patients accepted ICDs based on physician advice, sometimes unaware of risks until later.
  • Patients declining ICDs perceived them as unnecessary or risks as inapplicable.

Conclusions:

  • Adherence to guidelines by cardiologists may hinder shared decision-making for ICDs.
  • Variability in ICD decision discussions indicates a need for improved patient-physician communication.
  • Enhancing the ICD decision-making process is crucial for patient understanding and autonomy.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...